BRAF and neoplasm: Among GNAS mutant colon cancers, we identified mutations in the KRAS and BRAF oncogenes in nine of the ten (90%) cases, a fraction that is significantly higher than the overall frequency of KRAS and BRAF mutations in the tumor cohort (P<0.0305, Fisher's exact test).